DYN
Dyne Therapeutics, Inc.Healthcare$18.84
▼ Bearish
Mkt Cap: $3.11B|Float: 155.1M|SI: 12.3%|DTC: 8.1
Data as of market close Apr 2, 2026
IV Rank
93
IV Pctl
67%
HV 20d
94.8%
52W Range
$6-$25
ATR(14)
$1.16
Exp. Move
±13.3%
P/C Ratio
2.33
Earnings
May 7
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
DYN Key Options Data
- IV Rank
- 92.7%
- Total GEX
- $-0.00B
- Total DEX
- $0.1M
- Max Pain
- $17.00
- Expected Move
- ±13.3%
- Put/Call OI
- 2.33
- Net Premium
- $0.2M
- Spot Price
- $18.84
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.50 | ±13.3% | $16.34 | $21.34 |
| 2026-05-15 | 43 | ±$2.55 | ±13.5% | $16.29 | $21.39 |
| 2026-06-18 | 77 | ±$2.50 | ±13.3% | $16.34 | $21.34 |
| 2026-07-17 | 106 | ±$2.75 | ±14.6% | $16.09 | $21.59 |
| 2026-10-16 | 197 | ±$5.05 | ±26.8% | $13.79 | $23.89 |
| 2026-12-18 | 260 | ±$11.00 | ±58.4% | $7.84 | $29.84 |
Explore DYN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.